PeerVoice Internal Medicine Audio PeerVoice

Visit https://www.peervoice.com/GSQ860 to view the entire programme with slides. After completing “David T. Rubin, MD, AGAF - What They Say and What They Think: Exploring Tools for Assessing Bowel Urgency in Patients with Ulcerative Colitis”, participants will be able to: Discuss latest evidence on bowel urgency in patients with ulcerative colitis (UC) and its influence on quality of life; Analyze current communication gaps between patients with UC and clinicians during clinic visits; and Recognize the benefits and limitations of current patient-reported outcomes tools.

Visit https://www.peervoice.com/GYJ860 to view the entire programme with slides. After completing “Franco Cecchi, MD - Improving Collaborative Care for HCM: Tips and Tricks From the Multidisciplinary Cardiology Team”, participants will be able to: Identify practical strategies to improve the timely diagnosis of hypertrophic cardiomyopathy (HCM) within their own practice and through facilitation of multidisciplinary care and referrals; Use effective strategies for selection of cardiac imaging techniques to improve diagnosis, assessment, and monitoring of patients with HCM; and Assess the potential role of novel pharmacologic and invasive treatments within the existing treatment paradigm for HCM.

Visit https://www.peervoice.com/WYS860 to view the entire programme with slides. After completing “Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More”, participants will be able to: Explain the role of neuroinflammation in Alzheimer’s disease (AD); Identify the cells involved in driving chronic neuroinflammation; and Describe the vascular and systemic contributors to neuroinflammation.

Visit https://www.peervoice.com/AVK860 to view the entire programme with slides. After completing “Mauro Bernardi, MD - The Functional Quality of Albumin in Fluid Management of Patients with Liver Cirrhosis: Just a Concept or Does it Matter?”, participants will be able to: Explain the concept of functional quality of albumin; Describe the importance of the non-oncotic properties of albumin in the management of patients with liver cirrhosis; and Propose how functional quality of albumin may impact the management of patients with liver cirrhosis.

Visit https://www.peervoice.com/BDT860 to view the entire programme with slides. After completing “Ronald van Vollenhoven, MD, PhD - Managing Patients with Lupus: When Should We Escalate Treatment? ”, participants will be able to: Explain the impact of suboptimal disease control on the progression of systemic lupus erythematosus (SLE); Identify patient and disease characteristics that may influence treatment decision-making in patients with moderate-severe SLE and improve long-term outcomes; Evaluate opportunities to optimise management of patients with moderate-severe SLE; and Apply effective treatment plans to optimise clinical and quality of life (QoL) outcomes for patients with moderate-severe SLE.

Visit https://www.peervoice.com/AJZ860 to view the entire programme with slides. After completing “Payal Patel, MD, MPH - Rapid Diagnostic Testing: Getting the Upper Hand on Respiratory Tract Infections”, participants will be able to: Discuss the importance of rapid diagnostic testing for improving outcomes in patients with respiratory tract infections; Describe the link between rapid diagnostic testing, antimicrobial stewardship, and treatment decision-making; and Formulate optimal diagnostic testing plans for patients with respiratory tract infections.